741 related articles for article (PubMed ID: 15893163)
41. Evidence for executive deficits among users of MDMA (Ecstasy).
Fisk JE; Montgomery C; Murphy P; Wareing M
Br J Psychol; 2004 Nov; 95(Pt 4):457-66. PubMed ID: 15527532
[TBL] [Abstract][Full Text] [Related]
42. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.
Parrott AC; Lasky J
Psychopharmacology (Berl); 1998 Oct; 139(3):261-8. PubMed ID: 9784083
[TBL] [Abstract][Full Text] [Related]
43. A review of the acute subjective effects of MDMA/ecstasy.
Baylen CA; Rosenberg H
Addiction; 2006 Jul; 101(7):933-47. PubMed ID: 16771886
[TBL] [Abstract][Full Text] [Related]
44. Memory deficits associated with recreational use of "ecstasy" (MDMA).
Morgan MJ
Psychopharmacology (Berl); 1999 Jan; 141(1):30-6. PubMed ID: 9952062
[TBL] [Abstract][Full Text] [Related]
45. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.
Clemens KJ; McGregor IS; Hunt GE; Cornish JL
Drug Alcohol Rev; 2007 Jan; 26(1):9-15. PubMed ID: 17364831
[TBL] [Abstract][Full Text] [Related]
46. Syllogistic reasoning performance in MDMA (Ecstasy) users.
Montgomery C; Fisk JE; Newcombe R; Wareing M; Murphy PN
Exp Clin Psychopharmacol; 2005 May; 13(2):137-45. PubMed ID: 15943546
[TBL] [Abstract][Full Text] [Related]
47. Hippocampal remodelling after MDMA neurotoxicity: a single case study.
Nifosì F; Martinuzzi A; Toffanin T; Costanzo R; Vestri A; Battaglia M; Bertagnoni GE; Lupi A; Amistà P; Carollo C; Perini G
World J Biol Psychiatry; 2009; 10(4 Pt 3):961-8. PubMed ID: 18609419
[TBL] [Abstract][Full Text] [Related]
48. Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use.
Bedi G; Van Dam NT; Redman J
J Psychopharmacol; 2010 Feb; 24(2):233-40. PubMed ID: 18832429
[TBL] [Abstract][Full Text] [Related]
49. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
Reay JL; Hamilton C; Kennedy DO; Scholey AB
J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712
[TBL] [Abstract][Full Text] [Related]
50. [3,4-methylenedioxymethamphetamine ('ecstasy'): its long-term emotional and cognitive effects, and serotonin depletion].
Molero-Chamizo A
Rev Neurol; 2005 Jul 16-31; 41(2):108-14. PubMed ID: 16028190
[TBL] [Abstract][Full Text] [Related]
51. Impaired cognitive performance in drug free users of recreational ecstasy (MDMA).
Gouzoulis-Mayfrank E; Daumann J; Tuchtenhagen F; Pelz S; Becker S; Kunert HJ; Fimm B; Sass H
J Neurol Neurosurg Psychiatry; 2000 Jun; 68(6):719-25. PubMed ID: 10811694
[TBL] [Abstract][Full Text] [Related]
52. Executive function in abstinent MDMA ('ecstasy') users.
Zakzanis KK; Young DA
Med Sci Monit; 2001; 7(6):1292-8. PubMed ID: 11687745
[TBL] [Abstract][Full Text] [Related]
53. The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy.
Sumnall HR; Cole JC; Jerome L
J Psychopharmacol; 2006 Sep; 20(5):670-82. PubMed ID: 16401654
[TBL] [Abstract][Full Text] [Related]
54. Stimulant effects of 3,4-methylenedioxymethamphetamine (MDMA) 75 mg and methylphenidate 20 mg on actual driving during intoxication and withdrawal.
Ramaekers JG; Kuypers KP; Samyn N
Addiction; 2006 Nov; 101(11):1614-21. PubMed ID: 17034441
[TBL] [Abstract][Full Text] [Related]
55. The effects of stereotype threat on cognitive function in ecstasy users.
Cole JC; Michailidou K; Jerome L; Sumnall HR
J Psychopharmacol; 2006 Jul; 20(4):518-25. PubMed ID: 16174670
[TBL] [Abstract][Full Text] [Related]
56. Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy.
Parrott AC
J Psychopharmacol; 2005 Jan; 19(1):71-83. PubMed ID: 15671132
[TBL] [Abstract][Full Text] [Related]
57. Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users.
Daumann J; Fischermann T; Heekeren K; Henke K; Thron A; Gouzoulis-Mayfrank E
Psychopharmacology (Berl); 2005 Aug; 180(4):607-11. PubMed ID: 15372137
[TBL] [Abstract][Full Text] [Related]
58. Depressive symptomatology in young adults with a history of MDMA use: a longitudinal analysis.
Falck RS; Wang J; Carlson RG
J Psychopharmacol; 2008 Jan; 22(1):47-54. PubMed ID: 18187532
[TBL] [Abstract][Full Text] [Related]
59. Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.
Soar K; Parrott A; Turner J
J Psychopharmacol; 2009 Sep; 23(7):745-58. PubMed ID: 18635698
[TBL] [Abstract][Full Text] [Related]
60. Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study.
Schilt T; de Win MM; Koeter M; Jager G; Korf DJ; van den Brink W; Schmand B
Arch Gen Psychiatry; 2007 Jun; 64(6):728-36. PubMed ID: 17548754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]